Absolute quantification of somatic DNA alterations in human cancer
about
Inferring clonal composition from multiple sections of a breast cancerTargeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumorsAn extensive evaluation of read trimming effects on Illumina NGS data analysisEstrogen receptor alpha gene amplification in breast cancer: 25 years of debateA Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1A landscape of driver mutations in melanomaPractical aspects of NGS-based pathways analysis for personalized cancer science and medicineEvaluation and consequences of heterogeneity in the circulating tumor cell compartmentTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsPatterns of Chromosomal Aberrations in Solid TumorsDeciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicineComputational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challengesBioinformatics for cancer immunology and immunotherapyBreast cancer intra-tumor heterogeneityCancer evolution: mathematical models and computational inferenceEmerging patterns of somatic mutations in cancerEvolution of the cancer genomeClonal evolution in hematological malignancies and therapeutic implicationsStroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionCo-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.SInC: an accurate and fast error-model based simulator for SNPs, Indels and CNVs coupled with a read generator for short-read sequence dataSF3B1 mutations in chronic lymphocytic leukemia.Comprehensive molecular characterization of clear cell renal cell carcinoma.Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.Mutational landscape of aggressive cutaneous squamous cell carcinomaGenomic Classification and Prognosis in Acute Myeloid Leukemia.Comprehensive molecular profiling of lung adenocarcinoma.Integrated genomic characterization of papillary thyroid carcinomaHypermutation in human cancer genomes: footprints and mechanismsPOLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial CancerComprehensive Molecular Portraits of Invasive Lobular Breast CancerThe somatic genomic landscape of glioblastomaDiscovery and saturation analysis of cancer genes across 21 tumour typesExome sequencing identifies BRAF mutations in papillary craniopharyngiomasStatistical Methods in Integrative GenomicsDiet and esophageal diseaseTranscriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53Statistical Inference in Hidden Markov Models Using k-Segment ConstraintsSpatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis
P2860
Q21145293-4ED49965-0952-474C-B891-A74FEA548FE7Q21183964-579D24D4-F959-4CA5-AA6B-D72B5AF8EE34Q21559489-3509AB6E-7B95-4B8A-8D87-7AD1C24D199DQ24273274-288FCA99-04D3-4B6F-8FCE-C40506DA1FAFQ24294219-1CB4C9A1-0A86-433E-B15C-2AC90CC714B5Q24603357-F3113BD9-8665-488F-9060-4456BBF441EAQ26748603-40AE002C-CC5B-4CF6-9476-7626180FC32EQ26765357-7A8BCD8D-E351-4461-965F-124B18226D37Q26776394-6AA05A88-F7EB-489C-B0FF-7C6495777476Q26786127-82A5536A-23FD-4E26-961A-9AC101409708Q26825186-1963F038-3D85-471D-9BA7-0840572ED8AEQ26864808-E093975C-DC4A-426B-AA98-585DB385879BQ26864876-B9591C79-47A3-4E8D-A1FF-8B4D9BF5A493Q27000086-1F498BDB-1E2B-4725-9703-F39D51519040Q27002537-E30655B6-5747-487A-933E-8FE31F0E6648Q27014126-3CEA4D61-A0D7-450D-A95D-6E37DE93D03AQ27020991-1B5FFA14-7224-441C-B294-32B06DB4E39FQ27027655-0BDD5AFA-ED96-4075-9A7D-38F734907F60Q27307642-BCDF6627-4A28-4098-8B85-DDA693249DFAQ27321859-7C5A921C-6DC0-4E51-92B5-B5EB57190965Q27345462-23AE52AE-6E85-4DCD-B167-67584BCBB872Q27496505-90FFD966-1D1C-4AF2-918C-340EB295E633Q27852162-9BCF9260-914B-4E37-9FE4-C5529928FE80Q27852374-3308A11A-D9D2-44A4-9062-637477CA20F9Q27852678-4ED0E108-009D-4F9F-96DC-D594CEFB9A24Q27853082-C953D50A-D3A3-4A98-8F4B-D995B54ED654Q27853389-B51CC597-AFB0-4CE5-9677-8C85D172DAACQ28244995-7C1EA328-4269-48E0-9107-8C39A63728D0Q28251986-65C5B29A-0EB4-40E5-9F79-8C831489145BQ28255066-619B9DC1-44DF-4CDF-9872-275CB5F63A70Q28260529-50C3C463-753E-4010-8D2B-C1BCBDD4BA31Q28268284-5BE65F60-0B61-4CF3-BBFE-200B9C014F65Q28300185-00F26602-C958-45D1-B246-2049684B98E8Q28305204-0E1D3BDF-AB64-4670-8367-69AE10BC1C36Q28305680-71C3680C-D6FF-4906-AC7C-9E0625F3696AQ28385219-F371FB39-2330-4F6D-BB05-330E24AC3F17Q28391919-4FDAC70D-EE4B-4D75-A34C-2B5EAFC9D372Q28552677-5AC9CC0B-2DC8-4E80-8CFA-C38905845A1DQ28602739-F49980D2-E424-407F-8B0B-ACAF5C7CDC9AQ28649475-1EA88B02-610E-4D9C-BDCD-1D87CAF510F0
P2860
Absolute quantification of somatic DNA alterations in human cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Absolute quantification of somatic DNA alterations in human cancer
@ast
Absolute quantification of somatic DNA alterations in human cancer
@en
Absolute quantification of somatic DNA alterations in human cancer
@nl
type
label
Absolute quantification of somatic DNA alterations in human cancer
@ast
Absolute quantification of somatic DNA alterations in human cancer
@en
Absolute quantification of somatic DNA alterations in human cancer
@nl
prefLabel
Absolute quantification of somatic DNA alterations in human cancer
@ast
Absolute quantification of somatic DNA alterations in human cancer
@en
Absolute quantification of somatic DNA alterations in human cancer
@nl
P2093
P2860
P50
P356
P1433
P1476
Absolute quantification of somatic DNA alterations in human cancer
@en
P2093
Aaron McKenna
Barbara A Weir
David Pellman
Douglas A Levine
Elena Helman
Peter W Laird
Rameen Beroukhim
Robert C Onofrio
Scott L Carter
P2860
P2888
P304
P356
10.1038/NBT.2203
P407
P577
2012-05-01T00:00:00Z